← Back
$SUPN All transactions

SUPERNUS PHARMACEUTICALS, INC.

F

$ Value

$360K

Shares

7,796

Price

$46

Filed

Oct 3

Insider

Name

Khattar Jack A.

Title

President, CEO

CIK

0001539937

Roles

Director Officer

Transaction Details

Transaction Date

2025-10-02

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,173,437

Footnotes

Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 19, 2021. | Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. | Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. | On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on April 30, 2021. | On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.

Filing Info

Accession No.

0001539937-25-000030

Form Type

4

Issuer CIK

0001356576

Khattar Jack A.'s History

Date Ticker Type Value
2025-10-09 SUPN M $2.1M
2025-10-09 SUPN $3.0M
2025-10-09 SUPN $79K
2025-10-09 SUPN M $0
2025-10-07 SCPH U
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-07 SCPH D $0
2025-10-02 SUPN M $57K

Other Insiders at SUPN (90d)

No other insider activity at this issuer in the last 90 days.